Dopamine, kidney, and hypertension: Studies in dopamine receptor knockout mice

Pediatric Nephrology

Volumn 23, Issue 12, 2008, Pages 2131-2146

  Wang, Xiaoyan ^a   Villar, Van Anthony M ^a   Armando, Ines ^a   Eisner, Gilbert M ^a   Felder, Robin A ^b   Jose, Pedro A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Dopamine receptor; Hypertension; Knockout mice; Renal function

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR;

BLOOD PRESSURE REGULATION; DIURESIS; DOPAMINE URINE LEVEL; DOPAMINERGIC SYSTEM; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; KNOCKOUT MOUSE; NATRIURESIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SODIUM EXCRETION; SODIUM TRANSPORT; VASOCONSTRICTION;

ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; HYPERTENSION; KIDNEY; MICE; MICE, KNOCKOUT; RECEPTORS, DOPAMINE; RECEPTORS, G-PROTEIN-COUPLED; SODIUM;

EID: 55649093750     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0901-3     Document Type: Review

References (221)

1. Hussain T, Lokhandwala MF (2003) Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 228:134-142
2. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA (2004) Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 19:233-246
3. Dickson ME, Sigmund CD (2006) Genetic basis of hypertension: Revisiting angiotensinogen. Hypertension 48:14-20
4. Osborn JW, Jacob F, Guzman P (2005) A neural set point for the long-term control of arterial pressure: Beyond the arterial baroreceptor reflex. Am J Physiol Regul Integr Comp Physiol 288:R846-R855
5. Premont RT, Gainetdinov RR (2007) Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69:511-534
6. Schioth HB, Fredriksson R (2005) The GRAFS classification system of G-protein coupled receptors in comparative perspective. Gen Comp Endocrinol 142:94-101
7. Amenta F, Barili P, Bronzetti E, Ricci A (1999) Dopamine D1-like receptor subtypes in the rat kidney: A microanatomical study. Clin Exp Hypertens 21:17-23
8. Glickstein SB, Schmauss C (2001) Dopamine receptor functions: Lessons from knockout mice [corrected]. Pharmacol Ther 91:63-83
9. Holmes A, Lachowicz JE, Sibley DR (2004) Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes. Neuropharmacology 47:1117-1134
10. 3 receptors. Neuroscience 112:39-49
11. 2 receptors. J Neurosci 22:8002-8009
12. Sibley DR (1999) New insights into dopaminergic receptor function using antisense and genetically altered animals. Annu Rev Pharmacol Toxicol 39:313-341
13. 3-preferring agonist (+)-PD 128907 on dialysate dopamine levels. Neuropharmacology 48:43-50
14. 1 dopamine receptor function. Cardiovasc Hematol Agents Med Chem 4:369-377
15. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93:1945-1949
16. Albrecht FE, Drago J, Felder RA, Printz MP, Eisner GM, Robillard JE, Sibley DR, Westphal HJ, Jose PA (1996) Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 97:2283-2288
17. 3 receptor gene produces renin-dependent hypertension. J Clin Invest 102:493-498
18. 4 receptor-mediated presynaptic inhibition of GABAergic transmission in the rat supraoptic nucleus. J Neurophysiol 90:559-565
19. 2 receptors. Nature 377:424-428
20. 4 dopamine receptor-deficient mice. Hypertension 47:288-295
21. 2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 72:148-156
22. 1A dopamine receptors. Proc Natl Acad Sci USA 91:12564-12568
23. 5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22:10801-10810
24. Li XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein DS, Rubinstein M, Eisner GM, Jose PA (2001) Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension 38:303-308
25. 4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90:991-1001
26. Ueda A, Ozono R, Oshima T, Yano A, Kambe M, Teranishi Y, Katsuki M, Chayama K (2003) Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Am J Hypertens 16:853-858
27. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM (2006) Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 103:17985-17990
28. Granger JP, Schnackenberg CG (2000) Renal mechanisms of angiotensin II-induced hypertension. Semin Nephrol 20:417-425
29. Nasjletti A (1998) The role of eicosanoids in angiotensin-dependent hypertension. Hypertension 31:194-200
30. Raizada MK, Der Sarkissian S (2006) Potential of gene therapy strategy for the treatment of hypertension. Hypertension 47:6-9
31. Touyz RM (2005) Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: Role of angiotensin II. Exp Physiol 90:449-455
32. 1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int 62:790-798
33. 1 receptor protein in the human heart and kidney. Hypertension 30:725-729
34. 1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int 66:2167-2180
35. 1 receptors in the brain and parathyroid gland. Mol Pharmacol 36:566-574
36. Felder RA, Jose PA (1988) Dopamine1 receptors in rat kidneys identified with 125 I-Sch 23982. Am J Physiol 255:F970-F976
37. Felder RA, Kinoshita S, Ohbu K, Mouradian MM, Sibley DR, Monsma FJ Jr, Minowa T, Minowa MT, Canessa LM, Jose PA (1993) Organ specificity of the dopamine1 receptor/adenylyl cyclase coupling defect in spontaneously hypertensive rats. Am J Physiol 264:R726-R732
38. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA (1990) Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 15:560-569
39. Hedge SS, Ricci A, Amenta F, Lokhandwala MF (1989) Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. J Pharmacol Exp Ther 251:1237-1245
40. 3H]Sch 23390. Am J Physiol 257:F414-F423
41. Takemoto F, Satoh T, Cohen HT, Katz AI (1991) Localization of dopamine-1 receptors along the microdissected rat nephron. Pflugers Arch 419:243-248
42. O'Connell DP, Aherne AM, Lane E, Felder RA, Carey RM (1998) Detection of dopamine receptor D1A subtype-specific mRNA in rat kidney by in situ amplification. Am J Physiol 274:F232-F241
43. Yamaguchi I, Jose PA, Mouradian MM, Canessa LM, Monsma FJ Jr, Sibley DR, Takeyasu K, Felder RA (1993) Expression of dopamine D1A receptor gene in proximal tubule of rat kidneys. Am J Physiol 264:F280-F285
44. Yamaguchi I, Yao L, Sanada H, Ozono R, Mouradian MM, Jose PA, Carey RM, Felder RA (1997) Dopamine D1A receptors and renin release in rat juxtaglomerular cells. Hypertension 29:962-968
45. 1 receptor interaction in spontaneously hypertensive rats. Hypertension 42:787-792
46. 1 dopamine receptor: Expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain. Mol Pharmacol 44:918-925
47. Kruse MS, Adachi S, Scott L, Holtback U, Greengard P, Aperia A, Brismar H (2003) Recruitment of renal dopamine 1 receptors requires an intact microtubulin network. Pflugers Arch 445:534-539
48. O'Connell DP, Botkin SJ, Ramos SI, Sibley DR, Ariano MA, Felder RA, Carey RM (1995) Localization of dopamine D1A receptor protein in rat kidneys. Am J Physiol 268:F1185-F1197
49. Maeda Y, Terada Y, Nonoguchi H, Knepper MA (1992) Hormone and autacoid regulation of cAMP production in rat IMCD subsegments. Am J Physiol 263:F319-F327
50. 2 dopamine receptors produced by alternative RNA splicing. Nature 342:926-929
51. 2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function. Neuropharmacology 50:595-605
52. 2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci USA 100:4305-4309
53. 2 subfamily of dopamine receptor genes in kidney. Am J Physiol 266:F646-F650
54. 2-like dopamine receptors in the kidney of the spontaneously hypertensive rat. J Hypertens 21:199-207
55. 2 receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells. J Am Soc Nephrol 12:1844-1852
56. 3 receptor in the rat kidney. Eur J Pharmacol 338:89-95
57. 3 receptor in proximal tubules of the rat kidney. J Histochem Cytochem 52:1647-1655
58. 3 receptor protein in the rat kidney. Hypertension 32:886-895
59. 3 receptors in rat juxtaglomerular cells. Clin Exp Hypertens 19:93-105
60. 2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 281:R1071-R1078
61. 3 dopamine receptors in renal proximal tubule cells of spontaneously hypertensive rats. Hypertension 41:724-729
62. 3 deficient mice is associated with increased Na transporters in kidney (abstract). J Am Soc Nephrol 16:350A
63. 4 receptor. Mol Brain Res 29:157-162
64. 4 receptor expression in rat kidney: evidence for pre- and postjunctional localization. Histochem Cytochem 50:1091-1096
65. 5 dopamine receptor inhibition of the angiotensin type I receptor. Hypertension 51:1-7
66. 5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 288:H55-H61
67. Yao L, Ruan X, Arendshorst WJ, Jose PA (1995) Dopamine receptor subtype (D1A and D1B) expression in rat renal microvessels (abstract). Pediatr Res 37:374A
68. 5 dopamine receptors in the nephron. Hypertension 41:604-610
69. Amenta F (1997) Light microscope autoradiography of peripheral dopamine receptor subtypes. Clin Exp Hypertens 19:27-41
70. Yao LP, Huque E, Baraniuk J, Carey RM, Felder RA, Jose PA (1996) Dopamine receptor subtype expression (D1A and D1B) in rat nephron segments (abstract). J Invest Med 44:305A
71. 1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int 70:1072-1079
72. 5 dopamine receptors in renal proximal tubule cells. Hypertension 45:804-810
73. Carey RM, Siragy HM, Ragsdale NV, Howell NL, Felder RA, Peach MJ, Chevalier RL (1990) Dopamine-1 and dopamine-2 mechanisms in the control of renal function. Am J Hypertens 3:59S-63S
74. Felder RA, Wang X, Gildea J, Bengra C, Sasaki M, Zeng C, Jones JE, Zheng W, Asico LD, Jose PA (2003) Human renal angiotensin type 1 receptor regulation by the D1 dopamine receptor (abstract). Hypertension 42:438A
75. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 21:767-771
76. Teirstein PS, Price MJ, Mathur VS, Madyoon H, Sawhney N, Baim DS (2006) Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization. Am J Cardiol 97:1076-1081
77. Sanada H, Xu J, Watanabe H, Jose PA, Felder RA (2000) Differential expression and regulation of dopamine-1 (D-1) and dopamine-5 (D-5) receptor function in human kidney (abstract). Am J Hypertens 13:156A
78. 1A receptor induces antinatriuresis in conscious rats. Hypertension 33:504-510
79. +-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 252:F39-F45
80. Asghar M, Hussain T, Lokhandwala MF (2003) Overexpression of PKC-βI and -δ contributes to higher PKC activity in the proximal tubules of old Fischer 344 rats. Am J Physiol Renal Physiol 285:F1100-F1107
81. Bacic D, Kaissling B, McLeroy P, Zou L, Baum M, Moe OW (2003) Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int 64:2133-2141
82. 1 receptor dysfunction is acquired and not inherited in obese Zucker rats. Am J Physiol Renal Physiol 287:F109-F116
83. 1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: Mechanism of action. Eur J Pharmacol 473:185-190
84. + exchanger (NHE3) endocytosis via clathrin-coated vesicles: Dependence on protein kinase A-mediated NHE3 phosphorylation. J Biol Chem 276:26906-26915
85. Gomes P, Soares-da-Silva P (2004) Dopamine acutely decreases type 3 Na(+)/H(+) exchanger activity in renal OK cells through the activation of protein kinases A and C signalling cascades. Eur J Pharmacol 488:51-59
86. + exchanger interactions in the kidney in hypertension. Hypertension 36:395-399
87. Fryckstedt J, Meister B, Aperia A (1992) Control of electrolyte transport in the kidney through a dopamine- and cAMP-regulated phosphoprotein, DARPP-32. J Auton Pharmacol 12:183-189
88. +-2Cl-cotransport in rat medullary thick ascending limb by dopamine. Am J Physiol 271:R1561-R1567
89. +/ phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol 288:F740-F747
90. Baines AD, Drangova R (1998) Does dopamine use several signal pathways to inhibit Na-Pi transport in OK cells? J Am Soc Nephrol 9:1604-1612
91. + exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol 259:F297-F303
92. 3- cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int 57:534-543
93. 3 - exchanger in immortalized SHR proximal tubular epithelial cells. Am J Physiol Renal Physiol 286:F1120-F1126
94. Kocinsky HS, Girardi AC, Biemesderfer D, Nguyen T, Mentone S, Orlowski J, Aronson PS (2005) Use of phospho-specific antibodies to determine the phosphorylation of endogenous Na+/H+ exchanger NHE3 at PKA consensus sites. Am J Physiol Renal Physiol 289:F249-258
95. +-ATPase in rat renal proximal tubules. Eur J Pharmacol 411:61-66
96. + ATPase activity through protein kinase A. Mol Pharmacol 43:281-285
97. Efendiev R, Cinelli AR, Leibiger IB, Bertorello AM, Pedemonte CH (2006) FRET analysis reveals a critical conformational change within the Na,K-ATPase alpha1 subunit N-terminus during GPCR-dependent endocytosis. FEBS Lett 580:5067-5070
98. +-ATPase in kidney of spontaneously hypertensive rats. Clin Exp Hypertens 18:963-974
99. +-ATPase activity in the proximal tubule. Am J Physiol Renal Physiol 292:F1435-F1442
100. +-ATPase. Am J Physiol 269:F673-F680
101. Nowicki S, Kruse MS, Brismar H, Aperia A (2000) Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells. Am J Physiol Cell Physiol 279:C1812-C1818
102. Ominato, Satoh MT, Katz AI (1996) Regulation of Na-KATPase activity in the proximal tubule: Role of the protein kinase C pathway and of eicosanoids. J Membr Biol 152:235-243
103. Satoh T, Cohen HT, Katz AI (1992) Intracellular signaling in the regulation of renal Na-K-ATPase. I. Role of cyclic AMP and phospholipase A2. J Clin Invest 89:1496-1500
104. Hussain T, Abdul-Wahab R, Kotak DK, Lokhandwala MF (1998) Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules. Hypertension 32:1054-1059
105. Satoh T, Cohen HT, Katz AI (1993) Different mechanisms of renal Na-K-ATPase regulation by protein kinases in proximal and distal nephron. Am J Physiol 265:F399-F405
106. 1 receptor and protein kinase C isoforms in spontaneously hypertensive rats. Hypertension 32:1049-1053
107. Pedrosa R, Gomes P, Soares-da-Silva P (2004) Distinct signalling cascades downstream to Gsalpha coupled dopamine D1-like NHE3 inhibition in rat and opossum renal epithelial cells. Cell Physiol Biochem 14:91-100
108. 2+ uptake through cAMP, PLC/PKC, and MAPKs in renal proximal tubule cells. J Cell Physiol 211:486-494
109. Sheikh-Hamad D, Wang YP, Jo OD, Yanagawa N (1993) Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane. Am J Physiol 264:F737-F743
110. + exchanger. Am J Physiol 258:F514-F521
111. + regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J Biol Chem 278:28719-28726
112. Chen C, Lokhandwala MF (1995) Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats. Naunyn Schmiedebergs Arch Pharmacol 352:194-200
113. Clark KL, Hilditch A, Robertson MJ, Drew GM (1991) Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog. J Hypertens 9:1143-50
114. Chatziantoniou C, Ruan X, Arendshorst WJ (1993) Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am J Physiol 265:F845-F852
115. Cheng HF, Becker BN, Harris RC (1996) Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 97:2745-2752
116. 1 receptor interaction in spontaneously hypertensive rats. Hypertension 42:787-792
117. Salomone LJ, Howell NL, McGrath HE, Kemp BA, Keller SR, Gildea JJ, Felder RA, Carey RM (2007) Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism. Hypertension 49:155-161
118. 2 receptor. EMBO J 26:2127-2136
119. 2 receptor modulates sodium handling via local production of dopamine in the kidney. J Cardiovasc Pharmacol 42:S75-S79
120. +-ATPase in renal proximal tubules via the cAMP pathway. Eur J Pharmacol 321:259-263
121. 2-like receptors causes recruitment of tyrosine-phosphorylated NKA alpha 1-subunits in kidney. Am J Physiol Renal Physiol 283:F1290-F1295
122. Grider J, Kilpatrick E, Ott C, Jackson B (1998) Effect of dopamine on NaCl transport in the medullary thick ascending limb of the rat. Eur J Pharmacol 342:281-284
123. + ATPase activity in murine LTK2 cells. Mol Pharmacol 49:373-378
124. Agnoli GC, Borgatti R, Cacciari M, Garutti C, Ikonomu E, Lenzi P (1989) Antagonistic effects of sulpiride-racemic and enantiomers-on renal response to low-dose dopamine infusion in normal women. Nephron 51:491-498
125. Agnoli GC, Cacciari M, Garutti C, Ikonomu E, Lenzi P, Marchetti G (1987) Effects of extracellular fluid volume changes on renal response to low-dose dopamine infusion in normal women. Clin Physiol 7:465-479
126. Robinson SW, Caron MG (1997) Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor. Mol Pharmacol 52:508-14
127. Bek MJ, Zheng S, Xu J, Yamaguchi I, Asico LD, Sun XG, Jose PA (2001) Differential expression of adenylyl cyclases in the rat nephron. Kidney Int 60:890-899
128. Beazely MA, Watts VJ (2005) Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6. Cell Signal 17:647-653
129. Kanterman RY, Mahan LC, Briley EM, Monsma FJ Jr, Sibley DR, Axelrod J, Felder CC (1991) Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Mol Pharmacol 39:364-369
130. 2 receptor synergism. Nature 353:164-167
131. Aperia A, Eklof AC, Holtback U, Nowicki S, Sundelof M, Greengard P (1998) The renal dopamine system. Adv Pharmacol 42:870-873
132. Sarkis A, Lopez B, Roman RJ (2004) Role of 20-hydroxyeicosatetraenoic acid and epoxy- eicosatrienoic acids in hypertension. Curr Opin Nephrol Hypertens 13:205-214
133. 2 receptors in the plasma membrane. Biochemistry 45:8751-8759
134. 2 dopamine receptors: In marriage, a case of his, hers, and theirs. Sci STKE 2004:pE50
135. Cho DI, Quan W, Oak MH, Choi HJ, Lee KY, Kim KM (2007) Functional interaction between dopamine receptor subtypes for the regulation of c-fos expression. Biochem Biophys Res Commun 357:1113-1138
136. 2 dopamine receptor synergism. Nature 347:386-388
137. +-ATPase activity requires simultaneous activation of DA1 and DA2 receptors. Am J Physiol 259:F924-F928
138. Eklof AC (1997) The natriuretic response to a dopamine DA1 agonist requires endogenous activation of dopamine DA2 receptors. Acta Physiol Scand 160:311-314
139. 2- like receptors on renal function. Am J Physiol 275:R986-R994
140. 3 receptor functions? Biochem Pharmacol 52:511-518
141. 3 receptor activation modulates renal function in anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 358:690-693
142. 3 dopamine receptors in SHRs (abstract). Am J Hypertens 17:96A
143. + channels. Am J Physiol Renal Physiol 283:F114-F123
144. 3 receptors in the rat kidney: Role in physiology and pathophysiology. Acta Physiol Scand 168:219-223
145. Li L, Schafer JA (1998) Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct. Am J Physiol 275:F62-F67
146. Saito O, Ando Y, Kusano E, Asano Y (2001) Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD. Am J Physiol Renal Physiol 281:F114-F122
147. Chen CJ, Lokhandwala MF (1992) An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens 14:615-628
148. O'Connell DP, Ragsdale NV, Boyd DG, Felder RA, Carey RM (1997) Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension 29:115-122
149. Nielsen CB, Pedersen EB (1997) Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods. Clin Nephrol 47:304-309
150. Chen C, Beach RE, Lokhandwala MF (1993) Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension 21:364-372
151. Felder CC, Jose PA, Axelrod J (1989) The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther 248:171-175
152. Albrecht FE, Xu J, Moe OW, Hopfer U, Simonds WF, Orlowski J, Jose PA (2000) Regulation of NHE3 activity by G protein subunits in renal brush-border membranes. Am J Physiol Regul Integr Comp Physiol 278:R1064-1073
153. Kinoshita S, Sidhu A, Felder RA (1989) Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 84:1849-1856
154. Ohbu K, Felder RA (1993) Nephron specificity of dopamine receptor-adenylyl cyclase defect in spontaneous hypertension. Am J Physiol 264:F274-F279
155. Hussain T, Lokhandwala MF (1997) Renal dopamine DA1 receptor coupling with G S and G q/11 proteins in spontaneously hypertensive rats. Am J Physiol 272:F339-F346
156. Jose PA, Eisner GM, Felder RA (1993) Dopaminergic defect in hypertension. Pediatr Nephrol 7:859-864
157. Michel MC, Siepmann F, Buscher R, Philipp T, Brodde OE (1993) Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. I. Renal alpha 1-, alpha 2-, and beta-adrenergic receptors and their signaling. Hypertension 22:169-177
158. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, Felder RA (1999) Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 33:1036-1042
159. Lao YS, Hendley ED, Felder RA, Jose PA (2002) Elevated renal cortical calmodulin- dependent protein kinase activity and blood pressure. Clin Exp Hypertens 24:289-300
160. Ohbu K, Hendley ED, Yamaguchi I, Felder RA (1993) Renal dopamine-1 receptors in hypertensive inbred rat strains with and without hyperactivity. Hypertension 21:485-490
161. Krushkal J, Xiong M, Ferrell R, Sing CF, Turner ST, Boerwinkle E (1998) Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood
162. 1 receptor gene polymorphism is associated with essential hypertension. Hypertension 36:183-186
163. Beige J, Bellmann A, Sharma AM, Gessner R (2004) Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension. Am J Hypertens 17:1184-1187
164. Rao F, Wessel J, Wen G, Zhang L, Rana BK, Kennedy BP, Greenwood TA, Salem RM, Chen Y, Khandrika S, Hamilton BA, Smith DW, Holstein-Rathlou NH, Ziegler MG, Schork NJ, O'Connor DT (2007) Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism. Hypertension 49:1015-1031
165. Allayee H, de Bruin TW, Michelle Dominguez K, Cheng LS, Ipp E, Cantor RM, Krass KL, Keulen ET, Aouizerat BE, Lusis AJ, Rotter JI (2001) Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 38:773-778
166. Cravchik A, Gejman PV (1999) Functional analysis of the human D5 dopamine receptor missense and nonsense variants: Differences in dopamine binding affinities. Pharmacogenetics 9:199-206
167. 5 receptor null mutant mice. Behav Neurosci 115:1129-1144
168. 5 dopamine receptors. Cardiovasc Hematol Agents Med Chem 5:241-248
169. 5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 290:R96-R104
170. Wang Z, Armando I, Asico LD, Escano C, Wang X, Lu Q, Felder RA, Schnackenberg CG, Sibley DR, Eisner GM, Jose PA (2007) The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production. Am J Physiol Heart Circ Physiol 292:H2083-2092
171. 2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf) 55:605-611
172. 2 receptor gene TaqI polymorphism. Hypertension 36:177-182
173. Kren V, Pravenec M, Lu S, Krenova D, Wang JM, Wang N, Merriouns T, Wong A, St Lezin E, Lau D, Szpirer C, Szpirer J, Kurtz TW (1997) Genetic isolation of a region of chromosome 8 that exerts major effects on blood pressure and cardiac mass in the spontaneously hypertensive rat. J Clin Invest 99:577-581
174. 3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells. J Med Genet 41:867-871
175. 3 receptor gene is not associated with essential hypertension in the Japanese. Med Sci Monit 8:CR1-CR4
176. James K, Weitzel LR, Engelman CD, Zerbe G, Norris JM, Framingham Heart Study (2003) Genome scan linkage results for longitudinal systolic blood pressure phenotypes in subjects from the Framingham Heart Study. BMC Genet 4[Suppl 1]:S83
177. Rice T, Rankinen T, Province MA, Chagnon YC, Perusse L, Borecki IB, Bouchard C, Rao DC (2000) Genome-wide linkage analysis of systolic and diastolic blood pressure: The Quebec Family Study. Circulation 102:1956-1963
178. 3 receptors and salt-dependent hypertension. J Am Soc Nephrol 12:2272-2279
179. 3 receptor activation in spontaneously hypertensive rats. Hypertens Res 26:855-861
180. 1 angiotensin receptor expression in rat renal proximal tubule cells. Circ Res 99:494-500
181. Sanada H, Yatabe J, Midorikawa S, Katoh T, Hashimoto S, Watanabe T, Xu J, Luo Y, Wang X, Zeng C, Armando I, Felder RA, Jose PA (2006) Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension 47:1131-1139
182. 4 receptor variants in the human population. Nature 358:149-152
183. Sen S, Nesse R, Sheng L, Stoltenberg SF, Gleiberman L, Burmeister M, Weder AB (2005) Association between a Dopamine-4 receptor polymorphism and blood pressure. Am J Hypertens 18:1206-1210
184. 2 receptor-deficient mice. Hypertension 49:672-678
185. Armando I, Wang X, Pascua AM, Villar VAM, Luo Y, Jones JE, Asico L, Escano C, Jose PA (2007) Regulation of renal NADPH oxidase and inflammation by dopamine D-2 receptor (abstract). Circulation 116[Suppl]:124
186. 3 receptor knockout mice. Hypertens Res 30:93-101
187. Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, Paigen B (2001) Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics 71:70-77
188. Goldstein DS, Grossman E, Armando I, Wolfovitz E, Folio CJ, Holmes C, Keiser HR (1993) Correlates of urinary excretion of catechols in humans. Biog Amines 10:3-17
189. Gerlo EAM, Schoors DF, Dupont MG (1991) Age- and sex-related differences for the urinary excretion of norepinephrine, epinephrine, and dopamine in adults. Clin Chem 37:875-878
190. Lakatua DJ, Nicolau GY, Bogdan C, Plinga L, Jachimowicz A, Sackett-Lundeen L, Petrescu E, Ungureanu E, Haus E (1987) Chronobiology of catecholamine excretion in different age groups. Prog Clin Biol Res 227B:31-50
191. Vanpée M, Herin P, Lagercrantz H, Aperia A (1997) Effect of extreme prematurity on renal dopamine and norepinephrine excretion during the neonatal period. Pediatr Nephrol 11:46-8
192. Sulyok E, Gyódi G, Ertl T, Bódis J, Hartmann G (1985) The influence of NaCl supplementation on the postnatal development of urinary excretion of noradrenaline, dopamine, and serotonin in premature infants. Pediatr Res 19:5-8
193. Meister B, Fried G, Holgert H, Aperia A, Hökfelt T (1992) Ontogeny of aromatic L-amino acid decarboxylase-containing tubule cells in rat kidney. Kidney Int 42:617-623
194. Armando I, Nowicki S, Aguirre J, Barontini M (1995) A decreased tubular uptake of DOPA results in defective dopamine production in aged rats. Am J Physiol 268:F1087-F1092
195. Soares da Silva P, Fernandes MH (1991) A study of the renal synthesis of dopamine in aged-rats. Acta Physiol Scand 143:287-293
196. Soares-da-Silva P, Vieira-Coelho MA, Pestana M, Fernandes MH, Guimarães JT (1995) Ontogeny of the cell outward dopamine transporter in canine renal tissues. Fundam Clin Pharmacol 9:255-262
197. Tenore G, Barili P, Sabbatini M, Tayebati SK, Amenta F (1997) Postnatal development of dopamine D1-like and D2-like receptors in the rat kidney: a radioligand binding study. Mech Ageing Dev 95:1-11
198. Kinoshita S, Felder RA (1990) Ontogeny of DA1 receptor-adenylate cyclase coupling in proximal convoluted tubules. Am J Physiol 259:F971-F976
199. Svennilson J, Aperia A (1999) Dopamine in the developing kidney. Int J Dev Biol 43:441-443
200. Massmann GA, Zhang J, Rose JC, Figueroa JP (2006) Acute and long-term effects of clinical doses of antenatal glucocorticoids in the developing fetal sheep kidney. J Soc Gynecol Invest 13:174-180
201. Felder RA, Nakamura KT, Robillard JE, Kanadjian M, Jose PA (1988) Dopamine receptors in the developing sheep kidney. Pediatr Nephrol 2:156-162
202. Cantalamessa F, Barili P, Cavagna R, Sabbatini M, Tenore G, Amenta F (1998) Influence of neonatal treatment with the pyrethroid insecticide cypermethrin on the development of dopamine receptors in the rat kidney. Mech Ageing Dev 103:165-78
203. +- ATPase activity in the developing rat renal cortical and medullary tubule cells. Pediatr Res 34:308-311
204. Hussain T, Kansra V, Lokhandwala MF (1999) Renal dopamine receptor signaling mechanisms in spontaneously hypertensive and Fischer 344 old rats. Clin Exp Hypertens 21:25-36
205. Kansra V, Hussain T, Lokhandwala MF (1997) Alterations in dopamine DA1 receptor and G proteins in renal proximal tubules of old rats. Am J Physiol 273:F53-F59
206. Li XX, Xu J, Zheng S, Albrecht FE, Robillard JE, Eisner GM, Jose PA (2001) D 1 dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 280:R1650-R1660
207. Kaneko S, Albrecht F, Asico LD, Eisner GM, Robillard JE, Jose PA (1992) Ontogeny of DA1 receptor-mediated natriuresis in the rat: In vivo and in vitro correlations. Am J Physiol 263:R631-R638
208. Li XX, Albrecht FE, Robillard JE, Eisner GM, Jose PA (2000) Gβ regulation of Na/H exchanger-3 activity in rat renal proximal tubules during development. Am J Physiol Regul Integr Comp Physiol 278:R931-936
209. Buckely NM, Brazeau P, Frazier ID (1983) Cardiovascular effects of dopamine in developing swine. Biol Neonate 43:50-60
210. Fiser DH, Fewell JE, Hill DE, Brown AL (1988) Cardiovascular and renal effects of dopamine and dobutamine in healthy, conscious piglets. Crit Care Med 16:340-345
211. Gootman NB, Buckley BJ, Gootman PM, Nagelberg JS (1982) Age-related effects of single injections of dopamine on cardiovascular function in developing swine. Dev Pharmacol Ther 4:139-150
212. Vane DW, Weber TR, Caresky J, Grosfeld JL (1982) Systemic and renal effects of dopamine in the infant pig. J Surg Res 32:477-483
213. Nakamura KT, Felder RA, Jose PA, Robillard JE (1987) Effects of dopamine in the renal vascular bed of fetal, newborn, and adult sheep. Am J Physiol 252:R490-R497
214. Kohli JD, Goldberf LI (1987) Dopamine receptors: A classification based on physiological studies. In: Creese I, Fraser CM (eds) Dopamine receptors. Liss, New York, pp 97-114
215. Pelayo JC, Fildes RD, Jose PA (1984) Age-dependent renal effects of intrarenal dopamine infusion. Am J Physiol 247:R212-R216
216. Segal JL, Smith FG, Guillery EN, Jose PA, Robillard JE (1992) Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep. Am J Physiol 263:R868-R873
217. Seri I, Aperia A (1988) Contribution of dopamine2 receptors to dopamine-induced increase in glomerular filtration rate. Am J Physiol 254:F196-F201
218. Sulyok E (1988) Dopaminergic control of neonatal salt and water metabolism. Pediatr Nephrol 2:163-165 163-165
219. Holtback U, Aperia A (2003) Molecular determinants of sodium and water balance during early human development. Semin Neonatol 8:291-299
220. Cheung PY, Barrington KJ (1996) Renal dopamine receptors: Mechanisms of action and developmental aspects. Cardiovasc Res 31:2-6
221. Vieira-Coelho MA, Hussain T, Kansra V, Serrao MP, Guimaraes JT, Pestana M, Soares-Da-Silva P, Lokhandwala MF (1999) Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats. Hypertension 34:666-672